LUMA Vision has received FDA clearance for VERAFEYE, a groundbreaking platform that revolutionizes cardiac procedures. This innovation promises real-time visual guidance for improved outcomes.

LUMA Vision will unveil its groundbreaking VERAFEYE 4D Imaging Platform at the Heart Rhythm Society Annual Meeting in Chicago, highlighting a new era for electrophysiology.

LUMA Vision announces the expansion of its VERAFEYE™ platform to enhance catheter ablation procedures in Europe, showcasing innovative cardiac care technology.

LUMA Vision is expanding its clinical program with the innovative VERAFEYE™ platform for better cardiac procedures, underscoring European collaboration in health technology.

LUMA Vision Ltd. showcases its cutting-edge VERAFEYE™ System at the AF Symposium, enhancing cardiac imaging and navigation. Discover its innovative features now.

LUMA Vision Ltd. revolutionizes cardiac procedures with the successful completion of 15 VERAFEYE™-guided ablations, showcasing innovative imaging technology.

LUMA Vision's VERAFEYE™ platform demonstrates remarkable advancements in cardiac imaging, completing successful persistent AF procedures, reflecting a new era in cardiac care.

LUMA Vision announces FDA clearance for the VERAFEYE™ platform, a groundbreaking tool for 2D/4D cardiac imaging. Discover how it enhances precision in cardiac procedures.

LUMA Vision has received FDA clearance for its VERAFEYE platform, a breakthrough in cardiac imaging, which offers dynamic 2D and 4D visualization to enhance procedural precision.

Discover how LUMA Vision's innovative VERAFEYE™ platform successfully completed its first human procedures, advancing cardiac navigation and visualization techniques.

LUMA Vision has achieved a groundbreaking milestone with its VERAFEYE™ platform, enhancing procedures in cardiac navigation and visualization.